![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | May 2022
Updated guidance sets out good practice for trustees and administrators for processing defined benefit (DB) transfers.
Published on May 3, 2022, by the Pensions Administration Standards Association (PASA), the guidance sets out principles for achieving a “faster, safer and more efficient” transfer experience. These include the need for clear and timely member communications, keeping members and other third parties informed about delays, and wherever possible using standard transfer templates for scheme and member information requests.
The guidance also has practical tips for improving member experience, such as supplying an early retirement quote when a member is over normal minimum pension age and moving to online identity verification rather than asking for paper-based ID.
In the light of industry feedback, the final guidance does not set out specific timescales for tasks.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023